NCT00258102View on ClinicalTrials.gov

A Study of the Safety and Effectiveness of Levofloxacin Compared With Lomefloxacin in the Treatment of Complicated Urinary Tract Infections

PHASE3CompletedINTERVENTIONAL

Enrollment

603

Participants

Timeline

Start Date

January 31, 1993

Study Completion Date

January 31, 1995

Conditions

Urinary Tract InfectionsBacterial InfectionsBacteriuriaUrologic Diseases

Interventions

DRUG

Levofloxacin

All Listed Sponsors

collaborator

PriCara, Unit of Ortho-McNeil, Inc.

INDUSTRY

lead

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

INDUSTRY

NCT00258102 - A Study of the Safety and Effectiveness of Levofloxacin Compared With Lomefloxacin in the Treatment of Complicated Urinary Tract Infections | Biotech Hunter | Biotech Hunter